These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3654953

  • 41. Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.
    Jones RN, Thornsberry C, Barry AL, Ayers L, Brown S, Daniel J, Fuchs PC, Gavan TL, Gerlach EH, Matsen JM.
    J Clin Microbiol; 1984 Sep; 20(3):409-12. PubMed ID: 6490826
    [Abstract] [Full Text] [Related]

  • 42. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
    Fuchs PC, Barry AL, Thornsberry C, Jones RN, Gavan TL, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Antimicrobial activities of cefetamet against clinical isolates from urinary tract infection].
    Ishii Y, Suzuki Y, Ishihara R, Nakazawa A, Deguchi K.
    Jpn J Antibiot; 1996 Dec; 49(12):1073-84. PubMed ID: 9032594
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.
    Barry AL, Jones RN.
    J Clin Microbiol; 1990 Mar; 28(3):605-7. PubMed ID: 2182675
    [Abstract] [Full Text] [Related]

  • 48. RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria.
    Fuchs PC, Jones RN, Barry AL, Ayers LW, Gavan TL, Gerlach EH, Thornsberry C.
    Diagn Microbiol Infect Dis; 1987 May; 7(1):29-35. PubMed ID: 3121241
    [Abstract] [Full Text] [Related]

  • 49. Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin.
    Thomas MG, Lang SD.
    Antimicrob Agents Chemother; 1986 May; 29(5):945-7. PubMed ID: 3729354
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result.
    Jones RN, Zurenko GE.
    Diagn Microbiol Infect Dis; 1993 May; 17(4):313-6. PubMed ID: 8112047
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S, Hiraoka M, Inoue M, Tomatsu K, Hirano M, Mitsuhashi S.
    Drugs Exp Clin Res; 1989 May; 15(1):1-10. PubMed ID: 2663406
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD, Powell M, Fah YS, Seymour A, Yuan M.
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [Abstract] [Full Text] [Related]

  • 58. In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.
    Fuchs PC, Jones RN, Barry AL.
    Antimicrob Agents Chemother; 1990 May; 34(5):914-7. PubMed ID: 2193626
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.